Furthermore, we investigated the causal role of GDF15 by assessing whether GDF15 blockade via a selective monoclonal antibody (mAb2) could prevent MCT-induced anorexia, weight loss, fat loss, and muscle atrophy in this preclinical cardiac cachexia model. The gene discussed is GDF15; the disease is Anorexia.